AZ137
AZ137 is a selective, ATP-competitive type I HIPK4 inhibitor with an IC50 of 11 nM for hHIPK4. AZ137 inhibits HIPK4-dependent F-actin remodeling. AZ137 can be used for research on cutaneous squamous cell carcinoma.
For research use only. We do not sell to patients.
- Formula: C22H21N3O5
- Molecular Weight:407.42
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| HEK-293T | EC50 |
76 nM
|
Cellular target engagement of HIPK4 in intact HEK293T cells overexpressing HIPK4-NanoLuciferase fusion constructs assessed by NanoBRET assay after 2.5 hrs incubation with tracer and compound.
Cellular target engagement of HIPK4 in intact HEK293T cells overexpressing HIPK4-NanoLuciferase fusion constructs assessed by NanoBRET assay after 2.5 hrs incubation with tracer and compound.
|
42720483 |
| HEK-293T | EC50 |
16069 nM
|
Cellular target engagement of HIPK1 in intact HEK293T cells overexpressing HIPK1-NanoLuciferase fusion constructs assessed by NanoBRET assay after 2.5 hrs incubation with tracer and compound.
Cellular target engagement of HIPK1 in intact HEK293T cells overexpressing HIPK1-NanoLuciferase fusion constructs assessed by NanoBRET assay after 2.5 hrs incubation with tracer and compound.
|
42720483 |
| HEK-293T | EC50 |
11054 nM
|
Cellular target engagement of HIPK2 in intact HEK293T cells overexpressing HIPK2-NanoLuciferase fusion constructs assessed by NanoBRET assay after 2.5 hrs incubation with tracer and compound.
Cellular target engagement of HIPK2 in intact HEK293T cells overexpressing HIPK2-NanoLuciferase fusion constructs assessed by NanoBRET assay after 2.5 hrs incubation with tracer and compound.
|
42720483 |
| HEK-293T | EC50 |
15613 nM
|
Cellular target engagement of HIPK3 in intact HEK293T cells overexpressing HIPK3-NanoLuciferase fusion constructs assessed by NanoBRET assay after 2.5 hrs incubation with tracer and compound.
Cellular target engagement of HIPK3 in intact HEK293T cells overexpressing HIPK3-NanoLuciferase fusion constructs assessed by NanoBRET assay after 2.5 hrs incubation with tracer and compound.
|
42720483 |
| HEK-293T | EC50 |
2299 nM
|
Cellular target engagement of CLK1 in intact HEK293T cells overexpressing CLK1-NanoLuciferase fusion constructs assessed by NanoBRET assay after 2.5 hrs incubation with tracer and compound.
Cellular target engagement of CLK1 in intact HEK293T cells overexpressing CLK1-NanoLuciferase fusion constructs assessed by NanoBRET assay after 2.5 hrs incubation with tracer and compound.
|
42720483 |
| HEK-293T | EC50 |
4102 nM
|
Cellular target engagement of CLK2 in intact HEK293T cells overexpressing CLK2-NanoLuciferase fusion constructs assessed by NanoBRET assay after 2.5 hrs incubation with tracer and compound.
Cellular target engagement of CLK2 in intact HEK293T cells overexpressing CLK2-NanoLuciferase fusion constructs assessed by NanoBRET assay after 2.5 hrs incubation with tracer and compound.
|
42720483 |
| HEK-293T | EC50 |
6209 nM
|
Cellular target engagement of CLK4 in intact HEK293T cells overexpressing CLK4-NanoLuciferase fusion constructs assessed by NanoBRET assay after 2.5 hrs incubation with tracer and compound.
Cellular target engagement of CLK4 in intact HEK293T cells overexpressing CLK4-NanoLuciferase fusion constructs assessed by NanoBRET assay after 2.5 hrs incubation with tracer and compound.
|
42720483 |
| HEK-293T | EC50 |
11830 nM
|
Cellular target engagement of BMP2K in intact HEK293T cells overexpressing BMP2K-NanoLuciferase fusion constructs assessed by NanoBRET assay after 2.5 hrs incubation with tracer and compound.
Cellular target engagement of BMP2K in intact HEK293T cells overexpressing BMP2K-NanoLuciferase fusion constructs assessed by NanoBRET assay after 2.5 hrs incubation with tracer and compound.
|
42720483 |
| HEK-293T | EC50 |
912 nM
|
Cellular target engagement of DYRK2 in intact HEK293T cells overexpressing DYRK2-NanoLuciferase fusion constructs assessed by NanoBRET assay after 2.5 hrs incubation with tracer and compound.
Cellular target engagement of DYRK2 in intact HEK293T cells overexpressing DYRK2-NanoLuciferase fusion constructs assessed by NanoBRET assay after 2.5 hrs incubation with tracer and compound.
|
42720483 |
In Vitro
AZ137 is a potent inhibitor of recombinant hHIPK4 with an IC50 of 11 nM[1].
AZ137 (2.5 h) acts on HIPK4 with an EC50 of 76 nM in intact HEK293T cells[1].
AZ137 (2.5 h) demonstrates high selectivity for HIPK4 over HIPK1-3, CLK1/2/4, YSK4, BMP2K, and DYRK2 in cellular target engagement assays[1].
AZ137 (1.25 nM-25 μM; 24 h) has no significant effect on HEK293T cell viability at concentrations up to 25 μM[1].
AZ137 (0.2-5 μM) reverses HIPK4-driven F-actin remodeling in NIH-3T3 cells in a dose-dependent manner and restores normal actin architecture at 1 and 5 μM[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:HEK293T cells
-
Concentration:1.25 nM-25 μM
-
Incubation Time:24 h
-
Result:Exhibited no significant cytotoxicity at compound concentrations up to 25 μM.
Chemical Information
-
Molecular Weight 407.42
-
Formula C22H21N3O5
-
SMILES
COC1=C2C=C3C(N=CC(C#N)=C3NC4=CC=CC(OC)=C4OCCOCCO2)=C1
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Phalloidin F-actin cytoskeleton staining
Phalloidin F-actin staining detects polymerized filamentous actin in fixed and permeabilized specimens by using fluorescent phalloidin or phalloidin-derived phallotoxins that bind actin filaments and generate a fluorescence microscopy readout corresponding to F-actin organization, including stress fibers, cortical actin, filament bundles, and tissue-specific actin networks. Phalloidin stabilizes F-actin by reducing actin subunit dissociation from filament ends, and fluorescent phallotoxins were established as tools for visualizing actin-containing structures in eukaryotic cells.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)